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 Therapeutic alliance, the helping relationship that develops between client and 
therapist, is the most commonly studied process variable in mental health treatment.  In 
child/adolescent treatment, the relationship that develops between therapist and the 
youth’s caregiver has also been argued as important.  This is due to the routine 
involvement of caregivers in treatment tasks (e.g., learning new parenting skills), as well 
as their involvement in dictating the youth’s treatment goals and treatment agenda.    
Alliance is theorized not to remain static; it deteriorates or grows stronger over the course 
of treatment.  Yet despite alliance’s theorized volatility and instrumental role in 
predicting eventual treatment response, very little research has investigated whether 
longitudinal alliance change within client relates to outcome.  Using data from the 
Multimodal Treatment Study of Children with AD/HD, caregivers participating in the 
parent-training arm of the study were utilized to investigate how alliance growth affects 
outcome using statistical methods that can model appropriately within-client change 
 (hierarchical linear modeling, survival analysis).  Consistent with hypotheses, caregiver-
reported alliance was found to be significantly volatile within-clients and has different 
trajectories in early versus late treatment.  These findings call into question the utility of 
the alliance literature’s traditional means of summarizing therapeutic alliance (e.g., 
average overall alliance, one-session snapshots of alliance over phases of treatment).  
Contrary to the other hypotheses, treatment engagement variables did not consistently 
predict eventual treatment response, patterns of missing alliance data, or early 
termination from the study.   The only consistent predictor of outcome (i.e., treatment 
response and early termination), was treatment group assignment, which is consistent 
with the main findings of the study.  Explanations for the results of this study are 
generated, and the conclusion of the study outlines the new directions that can move the 
therapeutic alliance literature forward using advances in longitudinal statistics.    
 
 
 
 
 
 
 
 
 
 
 
 
EVALUATING THERAPEUTIC ALLIANCE LONGITUDINALLY: 
DESCRIBING THERAPEUTIC ALLIANCE GROWTH  
AND ITS IMPLICATIONS FOR OUTCOMES 
 
By 
 
Jeffrey J. Sapyta 
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY 
in 
Psychology 
August, 2006 
Nashville, Tennessee 
 
Approved: 
Professor Leonard Bickman 
Professor Craig Anne Heflinger 
Professor Steven D. Hollon 
 ii
ACKNOWLEDGEMENTS 
Jeffrey J.  Sapyta was supported in part with National Institute of Mental Health 
(NIMH) T32 MH19544-11A.  Special thanks also go to Peter S. Jensen and the larger 
research consortium for allowing the author to pursue therapeutic alliance research using 
data from the most important study to date on youth treatment for AD/HD:  The 
Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder 
(MTA). 
On a personal note, this project could not be completed without the charity and 
patience of numerous people.  I would like to thank Dr. Leonard Bickman for his 
guidance and support, as well as his commitment to scientific excellence.  I would also 
like to thank Dr. E. Warren Lambert for his wit, contagious laughter, and statistical 
assistance on numerous projects including this one.  Special commiseration awards go to 
the many that helped me slog through the milestones including Drs. Stephanie Reich, 
Tricia Lipani, Joan Walker, Wendy Garrard, and Annalise Caron.   
But my largest expression of gratitude goes to my darling wife, Dr. Nicole L. 
Schramm-Sapyta.  It was only by her enduring patience and love that ultimately kept me 
focused, inspired, and, on my best days, forging toward the finish line.   
 
 iii
TABLE OF CONTENTS 
 
Page 
ACKNOWLEDGEMENTS.................................................................................................... ii 
LIST OF TABLES...................................................................................................................v 
LIST OF FIGURES ................................................................................................................vi 
Chapter 
 
I. INTRODUCTION ..........................................................................................................1 
Empirical Evidence of Therapeutic Alliance in Child Studies ........................2 
Caregiver Therapeutic Alliance .......................................................................4 
Definition and Empirical Structure of Therapeutic Alliance...........................5 
Theories Describing How and Why Alliance Affects Outcomes ....................7 
Common Features of Theories Explaining the Alliance-Outcome 
Relationship ....................................................................................................10 
The Great Disconnect:  The Study of Alliance Longitudinally ......................11 
Future Directions in Therapeutic Alliance Research ......................................13 
Study Purpose .................................................................................................15 
 
II. METHOD ......................................................................................................................17 
Population Sample ..........................................................................................17 
Sampling and Data Collection ........................................................................17 
Measures .........................................................................................................19 
Caregiver Working Alliance Inventory- Short Version (C-WAI) .........19 
Swanson, Nolan, and Pelham AD/HD Checklist from the DSM-IV 
(SNAP-IV) .............................................................................................20 
Data Analysis ..................................................................................................20 
Hierarchical Linear Modeling................................................................20 
Pattern-Mixture Model Analysis............................................................22 
Assessing Treatment Dropout Using Survival Analysis........................23 
 
III. RESULTS ......................................................................................................................25 
Preliminary Analyses ......................................................................................25 
Caregiver Alliance Growth .............................................................................28 
Caregiver Alliance Growth Relationship to Outcome ....................................32 
Pattern Mixture Analysis ................................................................................39 
Survival Analysis ............................................................................................43 
 
IV. DISCUSSION................................................................................................................47 
 iv
Appendix 
 
A.      CONSTRUCTING PIECEWISE MODELS ................................................................59 
B.      PATTERN MIXTURE ANALYSIS DUMMY CODING............................................61 
 
REFERENCES .......................................................................................................................62 
 
 
 
 
 v
LIST OF TABLES 
Table Page 
 
1. Descriptive data for the caregiver working alliance inventory item  
 mean value and reflected log transformation…………………………………….25 
 
2. Descriptive data for the SNAP-IV total scale and subscales…………………….28 
 
3. Linear growth model of alliance throughout treatment (unconditional model)….29 
 
4. Linear growth model of alliance over the course of treatment (unconditional 
model) for subjects with sufficient data to construct a piecewise growth  
 model…………………………………………………….……………………….31 
 
5. Linear piecewise model of growth of alliance over the course of treatment  
(early slope and late slope)………………………………………………………32 
 
6. Unconditional model for caregiver-reported SNAP-IV AD/HD composite  
over the course of treatment (i.e., through 14-month time point)………………..34 
 
7. 14-month caregiver-reported AD/HD composite model including  
treatment group……………………………………………………..…………....36 
 
8. 14-month caregiver-reported AD/HD composite model including  
treatment group and piecewise alliance slopes…………………………………..37 
 
9. 24-month caregiver-reported AD/HD composite model including  
treatment group and piecewise alliance slopes……………………………….….40 
 
10. Frequency table of missing data patterns over early, middle, and late 
parent-training sessions………………………………………...……………...…41 
.. 
11. Cox regression analyses with covariates predicting premature termination…..…46 
 
 
 
 vi
LIST OF FIGURES 
 
Figure           Page 
 
 
1. Frequency of completed alliance data by session number……………………….27 
 
2. Linear growth model of therapeutic alliance by training session………………..30 
 
3. 14-month caregiver-reported AD/HD symptoms by treatment group……...……35 
 
4. Cumulative survival function of treatment dropout……………………………...37 
 
5. Cumulative survival of dropout by treatment group…………………………..…47
 1
CHAPTER 1 
 
INTRODUCTION 
 
Therapeutic alliance, the helping relationship that develops between client and 
therapist, is the most commonly studied process variable in mental health treatment 
(Horvath & Bedi, 2002).  Although it was discussed as an important component of the 
therapeutic relationship by prominent psychodynamic authors (e.g., Freud 1913/1966; 
Greenson, 1965; Zetzel, 1956), it remained a theoretical curiosity until the mid 1970s.  It 
was during this period that therapeutic alliance was first investigated as a predictor of 
outcome (e.g., Luborsky, 1976; Strupp & Hadley, 1979).  After 30 years of research, it is 
now considered by many as the best therapy process predictor of therapeutic outcome in 
adult populations (e.g., Horvath & Luborsky, 1993; Orlinsky, Grawe, & Parks, 1994).  
Besides “traditional” psychotherapy settings (i.e., outpatient services with a therapist), 
alliance has been predictive of outcomes in approaches as diverse as couples therapy, 
behavioral medicine, and pharmacotherapy (Bourgeois, Sabourin, & Wright, 1990; Gavin 
et al, 1999; Krupnick, Sotsky, Simmens, & Moyer, 1996). 
Since the operational definitions of alliance were developed in the 1970s, over 
2000 research publications have been published regarding therapeutic alliance (Horvath 
& Bedi, 2002).  A larger review of process variables found therapeutic bond to be the 
best predictor of outcome (Orlinksy, Grawe, & Parks, 1994).  However, this review only 
used vote-counting methods of significant findings, which is highly dependent on factors 
such as measurement reliability and sample size.  Furthermore, vote counting methods do 
not quantitatively address the strength of the relationship between alliance and outcome.  
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Parametric measures of effect size (e.g., r or Cohen’s d) can both describe the size of the 
relationship between two variables as well as if the relationship is significant.  Horvath 
and Symonds (1991) was the first meta-analysis to evaluate the relationship between 
outcome and therapeutic alliance.  Based on 24 studies, the average effect size was r = 
0.26.  Small, medium, and large effects for r are .10, .30, and .50, respectively (Cohen, 
1992).  Two other major meta-analyses on adult client therapeutic alliance have been 
recently conducted (Horvath & Bedi, 2002; Martin, Garske, & Davis, 2001).  Both of 
these reviews had larger study samples (i.e., 89 and 79 studies, respectively) use more 
sophisticated meta-analytic procedures (e.g., homogeneity of variance tests) and had 
similar effects (r = .21 & r= .22, respectively).  Tests for homogeneity of variance 
indicated that there were no significant moderator variables.  This finding is interesting, 
because it appears that the average alliance relationship to outcome in adult studies does 
not depend on type of rater, time of alliance assessment, type of treatment provided, or 
the publication status of the study.   
Empirical Evidence of Therapeutic Alliance in Child Studies 
Despite decades of investigation in adult populations, therapeutic alliance has 
only gained increased attention in child1 clinical outcome studies in the last 10 years (Eltz, 
Shirk, & Sarlin, 1995; Florsheim, Shotorbani, Guest-Warnick et al, 2000; Green, Kroll, 
Imrie et al, 2001; Hogue, Dauber, Stambaugh, Cecero, & Liddle, 2006).  One estimate 
indicates that less than 3% of child therapy studies have examined treatment processes 
like therapeutic alliance (Kazdin, Bass, Ayers, & Rodgers, 1990).  This has led some to 
                                                 
1 References to child studies includes studies where the primary clients are either children 
or adolescents. 
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describe treatment process research (i.e., research into within-treatment 
variables/interactions) as the “ignored stepchild of child psychotherapy investigators” 
(Russell & Shirk, 1998).  Although alliance in child community practice has not been 
evaluated with the rigor that it has had in adult psychotherapy, emerging evidence in 
inpatient adolescent services, youth day treatment, and the child welfare system indicate a 
similar relationship between alliance and outcome as in adult research clinics (Dore & 
Alexander, 1996; Colson, Cornsweet, Murphy et al, 1991; Eltz, Shirk, & Sarlin, 1995; 
Florsheim, Shotorbani, Guest-Warnick et al, 2000; Green, Kroll, Imrie et al, 2001).  An 
argument can be made that it may be more important in child mental health settings.  
Since most children enter therapy involuntarily and could be experiencing social deficits, 
the ability for the clinician to form and maintain a therapeutic relationship in child 
therapy is paramount (Shirk & Saiz, 1992).  Failure to establish a therapeutic alliance 
early in treatment could lead to dropout.  Data from child and family therapy studies 
suggest that as much as 30%-60% of participants terminate prematurely (Armbruster & 
Kazdin, 1994).  In cases where children/adolescents involved in residential treatment 
cannot decline treatment, low therapeutic alliance can presumably attenuate treatment 
effectiveness (Shirk, 2001).  Recently, a meta-analysis was conducted investigating the 
relationship between therapeutic alliance and outcome in child studies (Shirk & Karver, 
2003).  In a sample of 23 studies, the relationship was quite similar to adult studies of 
alliance (r=.21).  In contrast to the adult studies, several moderators were found.  Alliance 
was more related to outcome in externalizing children versus internalizing children 
(M= .30 vs. M= .10).  On methodological factors, alliance was more related to outcome 
on therapist- and observer-reported alliance than in the child (M = .29-.26 vs. M= .18).  
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Also, late session reports versus early session reports were more related to outcome (M 
= .27 versus M= .12).  Although alliance in child studies may have a similar overall 
relationship with outcome, it appears that some moderators of alliance that affect its 
relationship to outcome. 
Caregiver Therapeutic Alliance 
There is growing evidence that process research in youth treatment must also 
recognize the alliance between caregiver and therapist.  A survey of nearly 1200 child 
psychologists and psychiatrists cite parental cooperation as the only factor more 
important than the therapist-child relationship (Kazdin, Siegel, & Bass, 1990).  
Furthermore, theoretical papers on this topic have suggested that a therapeutic alliance 
with the parents or primary caregiver may in some cases be more important for treatment 
adherence and outcomes than the child’s relationship to the therapist (DiGiuseppe, 
Linscott, & Jilton, 1996).  Since the primary caregiver is often primarily in charge of 
providing/arranging transportation, payment, and establishing treatment goals, the 
caregiver could be considered more the “client” than the child (e.g., Weisz & Jensen, 
1999).  Attrition in child psychotherapy has been found to be more related to 
characteristics of the parent than the child (Gould, Schaffer, & Kaplan, 1985).  Recent 
empirical research has indicated that factors related to parental alliance affect 
engagement, attendance, and outcome (Kabuth, DeTychey, & Vidailhet, 2005; 
Morrissey-Kane & Prinz, 1999).  In the largest study to date of child/adolescent treatment 
dropouts in community outpatient settings, the most cited reason for dropping out of 
treatment by parents was therapeutic relationship problems (Garcia & Weisz, 2002).  This 
study illustrated that therapeutic alliance was more important for treatment engagement 
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and preventing premature dropout than if the child had improved or whether the child still 
needed treatment. 
Definition and Empirical Structure of Therapeutic Alliance 
The numerous therapeutic alliance measurement systems are currently based on 
only a few theoretical models.  All of these alliance models share two major factors in 
common: agreement on the agenda of therapy and the presence of a client emotional bond.  
Luborsky’s (1976) theory of alliance was the first to discriminate how alliance develops 
over time.  The first phase of alliance, Type I Alliance, involves the client’s belief that the 
therapist is helpful and provides a warm, supporting relationship.  Type II Alliance 
develops later, and it consists of the client’s commitment to the therapeutic process.  
Bordin (1979) described therapeutic alliance as a three factor model:  (1) the emotional 
bond between the client and therapist, (2) the agreement of the two parties on the 
therapeutic tasks, and (3) the agreement on the goals/expectations of therapy.  Gaston 
(1990) attempted to reconcile these previous theoretical models and current empirical 
therapist/client characteristic literature by proposing a four factor model:  (1) the patient’s 
capacity to purposefully work in therapy, (2) the client’s emotional bond to the therapist, 
(3) the therapist empathetic understanding and involvement, and (4) the patient-therapist 
agreement of tasks and goals.   
These modern conceptualizations of alliance have generated several measurement 
scales.  Luborsky (1976) developed a series of alliance measurement systems known 
collectively as the Penn Scales (HAcs; Luborsky, 1976; HAr; Luborsky, Crits-Christoph, 
Alexander, Margolis, & Cohen, 1983; HAq; Luborsky, McLellan, Woody, O’Brien, & 
Auerbach, 1985).  These were the first scales to be commonly used to measure 
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therapeutic alliance.  These instruments operationalized his Type I and Type II alliance 
constructs into therapist-, client-, and observer-rated alliance measures.  The Working 
Alliance Inventory, with factors tapping into bond, agreement on tasks, and agreement on 
goals is now the most widely used alliance measure today (WAI; Horvath & Greenberg, 
1989).  The California Psychotherapy Alliance Scales is also widely used, has versions 
for all three types of raters, and is based on Gaston’s (1990) four-factor theory (CALPAS; 
Marmar, Gaston, Gallagher, & Thompson, 1989).  Other measurement scales used to a 
lesser extent are the Vanderbilt Psychotherapy Process Scale (VPPS; Suh, Strupp, & 
O’Malley, 1986), Therapeutic Alliance Rating Scale (TARS; Marziali, 1984), and 
Therapeutic Bond Scales (Saunders, Howard, & Orlinsky, 1989).   
  Psychometric evaluation of the therapeutic alliance construct has not 
consistently supported multiple factors in the most widely used alliance measures.  High 
correlations between dimensions in these studies would indicate that therapeutic alliance 
would be best considered a unidimensional construct (e.g., Gaston, 1991; Morgan, 1982; 
Salvio, Beutler, Wood, & Engle, 1992).  However, other authors have argued elsewhere 
that a priori classical test theory methods of maximizing reliability and inter-item 
correlations in small validation samples could prevent viewing multidimensional patterns 
found in larger, more representative samples (Henry, Strupp, Schacht, & Gaston, 1994; 
Horvath & Greenberg, 1989).  Confirmatory factor analyses studying this issue have 
yielded both unidimensional and multidimensional factor solutions.  Tracey & Kokotovic 
(1989) compared the fit of the traditional Bordin (1979) model (i.e., 3 factors), one 
general factor, and a hierarchical 2-level factor on two samples that totaled 207 subjects.  
The hierarchical two-level model consisted of the three first-order factors as well as a 
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second-order general alliance factor, which loaded on each first-order factor.  None of the 
models fit the data well, but the hierarchical two-factor model had the best fit and was 
reported as the most adequate.  However, the authors failed to point out that more 
complicated models would always approximate the sample’s variance/covariance matrix 
better.  With a larger sample (i.e., 308 subjects), Gaston, Sabourin, Hatcher, & Hansell 
(1992) found additional evidence of a two-level model.  Four mildly correlated alliance 
instruments (i.e., resembling Gaston’s therapeutic alliance model) were imbedded in a 
larger alliance factor.  Sapyta (2001) investigated the factor structure of the therapeutic 
alliance instrument used in this study.  Although the hierarchical two-factor model was 
the best fitting model, the item loadings suggest each item loads highest on the general 
factor.  In everyday practice, it was suggested that clinicians use the overall mean, and 
not each individual factor. 
Theories Describing How and Why Alliance Affects Outcomes 
Many theorists have considered how the therapeutic relationship contributes to 
treatment engagement and therapeutic change.  Interestingly, very few of these 
individuals could be considered therapeutic alliance theorists per se.  Instead they have 
used the concept of alliance as part of larger perspective on psychotherapy.  Some 
approaches have included concepts that are basic to other fields such as social 
psychology.   Social influence theory describes counseling and the therapeutic 
relationship as a process of interpersonal influence (Strong, 1968).  Through charismatic 
qualities of the therapist (client-perceived expertness, trustworthiness, and attractiveness), 
the therapist reframes the client’s issues and attempts to change their behavior patterns or 
attitudes about the world.  This sometimes causes psychological discomfort or cognitive 
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dissonance, which then motivates the client to reduce the dissonance in several ways.  
Ideally under this model, the counselor can successfully persuade the client to accept the 
therapist’s model of change and dismiss their own objections.  This may take a few 
sessions of conflict, but eventually the client will come to agree and participate in the 
therapist’s model for change.  However, the client can also alleviate the dissonance of 
changing thoughts/behavior by essentially disengaging from the therapeutic process (e.g., 
reject the therapist’s claim entirely, discount the importance of alleviating this particular 
problem, or seek other sources or experts with a philosophy closer to their own).   
The phase model for psychotherapy is another theory that describes how the 
therapeutic relationship may affect therapeutic outcome (Howard, Lueger, Maling, & 
Martinovich, 1993).  Based on previous models of healing, they describe how therapists 
must provide a plausible rationale for the client’s distress (Frank & Frank, 1993; 
Luborsky, Singer, & Luborsky, 1975).  The phases of therapy include remoralization, 
remediation, and rehabilitation. This is a stage model, which specifies that a client cannot 
go into remediation until the client meets criteria of remoralization.  It is in the 
remoralization phase, where it is argued; developing the therapeutic relationship is 
paramount.  Based heavily on previous work by Frank & Frank (1993), the phase model 
of psychotherapy argues that clients seek therapy when they are no longer able to cope 
with their current strategies and begin to feel powerless and hopeless (i.e., demoralized).  
Clients then seek the services of a therapist who will build a therapeutic relationship with 
them.  In this relationship, the therapist will convey an aura of an expert, clarify the 
client’s presenting problem, and instill hope in the client for treatment success.  Once the 
client perceives the therapist as trustworthy/competent and has developed an emotional 
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bond with the therapist, the client will be willing to form goals based on the now 
reframed problems as well as participate in therapeutic tasks.  Thus, the initial therapeutic 
relationship fosters an allegiance to the therapist’s treatment model, which then leads to 
the activities of reducing the client’s symptoms, issues, etc.  Only after the establishment 
of a strong alliance, can the client work on relieving current symptoms (i.e., remediation) 
and perhaps changing maladaptive habits or personality characteristics after symptoms 
are reduced (i.e., rehabilitation).         
Besides the formal theories of psychotherapy process, there have been other 
attempts to explain how alliance relates to outcome based on empirical processes.  The 
role of client expectancies relationship with alliance has recently been gaining greater 
attention (Connolly-Gibbons et al, 2003; Joyce & Piper, 1998; Morrisey-Kane & Prinz, 
1999).  Client expectancies have been defined as the anticipatory beliefs that clients have 
regarding the procedures, outcomes, and any other aspect about the treatment rationale or 
its delivery (Nock & Kazdin, 2001).  Pretreatment expectancies have been found to be 
significantly associated with alliance (e.g., Joyce & Piper, 1998).  Although pretreatment 
expectancies are also related to outcome, it appears that this relationship is partially 
mediated by therapeutic alliance (Meyer et al, 2002).  These findings suggest that client 
expectancies may play a significant role in how the alliance is developed.  If a client has 
optimistic expectancies about treatment, the process of “persuading” the client of the 
treatment rationale may be easier than in clients with lower expectations.  Along with 
expectancies, some alliance theorists have described how within-client variation may 
predict treatment success.  A reasonably high but gradually increasing alliance through 
treatment has been indicated as predictive of better outcomes (Florsheim et al, 2000; 
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Joyce & Piper, 1998).  Others argue that the typical pattern of successful therapy is 
initially high, followed by lower alliance when the honeymoon period ends.  But in 
successful therapy cases, the alliance will be restored to its initial level.  Thus, successful 
treatment cases will resemble a “U-shaped” high-low-high pattern (Gelso & Carter, 1994).  
 Common Features of Theories Explaining the Alliance-Outcome Relationship 
The theories that describe how the therapeutic relationship affects outcome have 
several components that compliment each other.   Most notably, they all describe a 
temporal process regarding how alliance develops and fluctuates, with particular alliance 
development courses leading to improving or declining negative outcomes.  This is also a 
main tenet in one of the prominent alliance theories (Luborsky, 1976).  The expectancies 
literature also fits nicely in this approach, because expectancies of the client may affect 
how well the alliance can initially be developed.   A client already feeling optimistic 
about therapy success could have fewer reservations of establishing a good alliance early.  
Once therapy begins, the ability of a therapist to be persuasive (through being perceived 
as expert, trustworthy, and attractive) and the client’s expectations of therapy will 
determine if the therapist can successfully redefine the client’s problem, establish a 
treatment rationale, and instill hope that causes an emotional reaction in the client (i.e., 
bond to therapist).  Once this bond is formulated, it motivates the client to engage in the 
collaborative goals and tasks of therapy.  If this emotional bond is not adequately in place; 
the client will reject the therapist’s treatment rationale and will not improve due to the 
therapy.   
These conceptualizations also leave room for the client to question the therapist 
and therapeutic approach in the early stages of therapy.   In this early phase, there may be 
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a degree of volatility to the therapeutic relationship as the therapist both attempts to 
persuade the client in reframing their issues and simultaneously introducing the treatment 
rationale.  The few alliance articles that assess within-client variation longitudinally 
indicate that there is significant volatility of alliance, at least in the early phase of 
treatment (e.g., Kivlighan & Shaunessy, 2000).   Other researchers have described how 
alliance ruptures may happen occasionally at any point in treatment (Safran & Muran, 
1996).  Therefore, based on the theories described, clinicians and researchers should 
concentrate to both the level of alliance and the degree of volatility throughout treatment.  
The Great Disconnect:  The Study of Alliance Longitudinally 
Despite the large attention given to alliance’s role in outcome and the theories 
describing alliance volatility, there is very little research investigating whether 
longitudinal alliance change within-client relates to outcome.  According to alliance 
theorists, therapeutic alliance develops gradually and does not remain static throughout 
treatment.  Yet despite the assumed volatility of therapeutic alliance, only a few 
researchers in the extensive alliance literature have attempted to explain alliance 
volatility’s impact on outcome.  Bordin (1979) argued that the strength of the alliance 
depends on both the personal characteristics of the client and therapist and how these 
interact with the specific tasks they engage in throughout treatment.  Others have argued 
that the therapeutic relationship must be first grounded in trust of the therapist, which 
leads to commitment in the tasks and goals of therapy (Frank & Frank, 1993; Luborsky, 
1976).  Others hypothesize how different patterns of alliance development may impact 
eventual outcome (Gelso & Carter, 1994; Mann, 1973).  For instance, Mann’s (1973) 
description of clients truly engaged in time-limited therapy will begin treatment with a 
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level of optimism, followed by frustration as the therapist begins challenging their life 
patterns, and finally rebound to the level of initial engagement when they incorporate the 
therapist’s messages.  Finally, the research program at Beth Israel Medical Center 
currently has the most descriptive model of therapeutic alliance volatility:  therapeutic 
alliance ruptures (e.g., Safran & Muran, 2000; Safran, Muran, & Samstag, 1994).  They 
have developed taxonomy of different alliance ruptures and a stage-process model in 
identifying, attending, and repairing alliance ruptures.  Ruptures in alliance are argued as 
not only common but expected.  It is how the therapist handles a therapeutic alliance 
rupture, not the rupture itself, which eventually determines how responsive a client is to 
treatment.    
Despite the basic theoretical tenet that alliance development is a volatile process; 
the empirical approaches to investigating alliance have mostly neglected alliance as a 
longitudinal process.  Many alliance studies measure the alliance at only one point of 
time (Horvath & Marx, 1990).  Alliance in this way is typically operationalized as a one 
session snap shot (i.e., typically around the third session) or the average alliance 
throughout treatment (Horvath & Symonds, 1991). Others have examined the alliance 
over time by breaking the treatment into phases (e.g., thirds; early, middle, or late 
treatment).  They will then select randomly one session from each phase or average the 
alliance within a phase as one score (e.g., Hartley & Strupp, 1983).  Although these 
approaches yield group averages that are useful in identifying alliance-outcome 
relationships, they inform nothing about how within-person changes of alliance over time 
affect future treatment engagement or eventual clinical outcome (Henry, Strupp, Schacht, 
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& Gaston, 1994; Kivlighan & Shaughnessy, 2000).  To best understand how therapeutic 
alliance operates, you must not only know where the clients are but how they got there.   
Future Directions in Therapeutic Alliance Research 
Although therapeutic alliance has been consistently linked to outcome, most of 
the studies have only used autoregressive methods of linking a specific session, phase, or 
average alliance to outcome.  However, recent advances in longitudinal analyses can be 
utilized in therapeutic alliance research.  Hierarchical linear modeling (HLM) has the 
ability of simultaneously modeling a person’s initial level on a variable of interest as well 
as the patterns of change that occur within subject.  This approach has many benefits over 
previous methods of studying change such as repeated measures ANOVA (Nich & 
Carroll, 1997).  Some reports have studied how alliance change over time (i.e., growth) is 
related to subsequent outcome (Kivlighan & Shaughnessy, 1995, 2000).  The findings of 
these two studies were mixed, but a pattern of increasing alliance throughout treatment 
was consistently linked with positive outcome.  Replicating these initial longitudinal 
findings in other populations and settings are crucial for generalizing the effect of 
alliance longitudinal growth on therapy outcomes.  Another longitudinal method being 
used more commonly for treatment engagement research is survival analysis (Corning & 
Malofeeva, 2004; Woodside, Carter, & Blackmore, 2004).   For studying time until an 
event (e.g., treatment dropout), survival analysis is superior to traditional methods of 
studying longitudinal data such as OLS regression (Singer & Willett, 2003).  In fact, 
some have argued that most of psychotherapy termination research to date has been 
flawed due to the use of common use of statistical methods that do not correctly account 
for termination as a longitudinal process (Corning & Malofeeva, 2004).  For example, as 
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opposed to ANOVA or OLS regression, only survival analysis can accurately account for 
censored data (i.e, an event that has not yet occurred due to an arbitrary cause such as the 
data collection period ending).          
Another proposed method of improving the research on the effect of treatment 
engagement on outcome is to expand the scope of treatment engagement variables.  
Although therapeutic alliance has been the most often-studied process variable, the 
construct is mostly observed as client-reported data, which can contribute some 
traditional biases associated with self-report questionnaires (e.g., social desirability, 
recency effect).  Furthermore, studying alliance exclusively may be problematic due to 
growing evidence that many alliance instruments have ceiling effects (i.e., most patients 
have high alliances with therapist), which can lead to biased analyses due to truncated 
samples.  Therefore, treatment engagement should move toward involving several 
discrete variables that may all reflect treatment engagement in different ways.  Including 
variables such as pretreatment expectancies to treatment, homework completion, and 
treatment attendance collectively may give a more robust picture of treatment 
engagement’s impact on outcome.   
Another interesting application for studying change in therapeutic alliance is 
developing benchmarks for how alliance typically develops.  Since the growth of alliance 
through the course of treatment has not been adequately addressed, we simply do not 
know how alliance is established or fluctuates normatively.  Finding the typical growth of 
alliance can be useful in flagging clinicians when fluctuations of alliance are out of the 
ordinary and require additional attention.  This approach has been shown promising 
effects in systematically providing feedback to clinicians in symptoms/functioning 
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assessments.  Known as patient-focused research, this approach has shown to improve 
outcome and reduce premature termination in clients who are not doing well in therapy 
(Lambert et al, 2001).  A meta-analysis of providing feedback in this way has shown to 
significantly affect clinician behavior, treatment engagement, and to a lesser extent 
clinical outcome (Sapyta, 2004).  In light of these promising findings, finding the typical 
course of alliance in treatment is an important question by itself.  The following study 
will investigate how alliance growth typically occurs in treatment as well as its 
relationship to outcome.    
Study Purpose 
Using data from the 14-month long Multimodal Treatment Study of Children with 
AD/HD (MTA), this study will address several questions regarding studying 
longitudinally therapeutic alliance over the course of treatment:  (1) does therapeutic 
alliance fluctuate significantly over the course of treatment and to what extent does the 
volatility vary depending on the phase of treatment (i.e., early or late)?  According to the 
theories describing the therapeutic relationship, large volatility should be expected early 
in treatment as the client is being socialized into the treatment rationale described by the 
therapist.  It is hypothesized that the volatility in the sample should follow these theories 
with more volatility early in treatment.  The amount of volatility should then decline as 
therapy progresses.  (2) Does therapeutic alliance growth predict outcome over and above 
average alliance and does this relationship vary based on the phase of treatment (i.e., 
early or late)?  Although alliance will be related to outcome throughout treatment, early 
positive alliance is hypothesized as the most crucial for successful treatment response.  
Clients with high or growing alliance toward the end of the early phase of treatment are 
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predicted to have the best outcomes.  Previous process-outcome studies on therapeutic 
alliance typically assessed alliance at one time point (e.g., average alliance in treatment, 
one session in a large section of treatment). We will compare this approach with 
incorporating each client’s alliance slope as well.  (3) Do different patterns of missing 
alliance data predict treatment or alliance outcomes?   It is hypothesized that participation 
in therapeutic alliance procedures is a proxy to treatment engagement in general and thus 
should have a similar relationship to outcome.  Lack of participation in measurement 
procedures, especially after initial cooperation, could be an indicator of low treatment 
engagement.  (4) Are predictors such as therapeutic alliance, missing data patterns, and 
treatment group related to other treatment engagement variables such as premature 
dropout?  It is hypothesized that early therapeutic alliance growth will be a better 
predictor of treatment dropout than other alliance summary variables such as average TA.  
In particular, early engagement markers such as declining early alliance or sudden lack of 
participation in measurement procedures could be indicators that a client is at risk of 
terminating prematurely.  Not benefiting from the treatment assigned may also make one 
more at risk for termination, which may make those assigned to the less effective 
treatment (i.e., parent-training only) more at risk to dropout of treatment. 
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CHAPTER II 
 
METHOD 
 
Population Sample 
Participants for this study were from the Multimodal Treatment Study of Children 
with AD/HD (MTA).  In the MTA, 579 children with AD/HD and at least one caregiver 
for each child participated in a randomized controlled trial comparing four treatment 
strategies.  The children, aged 7.0-9.9 years of age, were assigned to 14 months of 
medication management (titration followed by monthly visits with a pharmacotherapist); 
intensive behavioral treatment which includes 35 parent-training sessions; the two 
combined; or routine community care.  The sample was 80% male and 61% Caucasian.  
Outcome measurement2 was collected during treatment at baseline, 3 months, 9 months, 
and 14 months.  Follow-up outcome measurement was also collected 10 months after the 
termination of treatment (i.e., 24 months after randomization).  For further details on the 
study methodology, see Arnold, 1997a, 1997b and MTA Cooperative Group, 1999. 
Sampling and Data Collection 
All families that were randomized to an experimental treatment (i.e., not 
community care) were eligible to complete the adapted Working Alliance Inventory-
Short for caregivers (CWAI-S).  After their scheduled treatment appointment, family 
                                                 
2 In practice, outcome measurement time intervals are approximate, not exact.  However, 
this is not problematic in HLM, due to its ability to model precisely the time between 
baseline and the respective data collection point. 
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members had the opportunity to complete a CWAI-S, place it in a sealed envelope, and 
give it to a research assistant on-site.   Of the 433 families eligible to complete a CWAI-S, 
334 families completed at least one.  Analyses indicate that families who participated had 
significantly lower teacher-reported baseline symptoms as measured by the SNAP 
Inattention mean item score (t (431)= -2.14, p < .05), SNAP ODD mean item score (t(431) 
= -2.04, p < .05), and SNAP Total mean score (t(431)= -3.24, p < .001).  In contrast, there 
were no significant differences on caregiver-reported baseline symptoms.  Teachers also 
reported significantly greater symptom reduction in participators as measured by mean 
item SNAP Inattention (t(431)= -2.45, p < .05) and SNAP Total mean score (t(431)= -
3.03, p < .003).  There were no caregiver-reported symptom reduction differences 
between participators and non-participators.   
Similar to the published papers on the MTA, only measures reported by biological 
mothers will be utilized for these analyses.  This was primarily done in the MTA because 
outcome measurement was mostly completed by biological mothers (MTA Cooperative 
Group, 1999).  In the parent-training and medication-management sessions, sometimes 
additional family members would complete alliance measures with the primary caregiver 
(e.g., Grandmother).  However a vast majority (68%) of the 1841 valid alliance measures 
were completed by biological mothers.  There were 439 biological father-reported 
measures (24%) and the rest were completed by grandparents, stepparents, or other 
family members.   
Only alliance measures from parent-training sessions were utilized for this 
longitudinal study.  The first reason for this was lack of more medication management 
participation.  While families in the parent-training and combined treatment groups had a 
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participation rate averaging 80 percent (81% and 79%, respectively), only 40% of 
families assigned to medication management-only treatment participated including two of 
the six treatment sites with no medication management participation at all.  More 
importantly the design of the study specified that medication management sessions had 
significantly fewer alliance measurement points, which is problematic for analyses 
studying longitudinal change.  Medication management session had only three 
“preferred” visits as opposed to six sessions preferred for parent-training sessions.  In 
practice only 50% of families with medication management sessions had three or more 
time points.  In contrast, 81% of parent-training sessions that had three or more time 
points.  Finally, a preliminary growth model found no differences on slope or intercept 
between parent-training and medication management sessions (t(286) = 1.18, p =.24; 
t(286) = -1.10, p =.28).  Therefore, due to the above reasons and to maximize power to 
detect differences using families in the combined treatment group, only parent-training 
sessions will be used.  The final sample size utilized for this study with mother-reported, 
parent-training sessions with linking outcome measurement was 229.    
Measures 
Caregiver Working Alliance Inventory- Short Version (C-WAI) 
The short version of the Working Alliance Inventory (WAI-Short; Tracey & 
Kokotovic, 1989) was adapted for use in the MTA study for caregiver-therapist 
therapeutic alliance.  It consists of 12 items on a 7-point likert scale with three subscales 
mapping directly on to the Bordin (1979) model of therapeutic alliance (i.e., agreement 
on tasks, agreement on goals, and bond).  The original WAI has consistently been 
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reported as highly reliable (i.e., α = .84-.92) and possessing adequate convergent (e.g., 
other alliance measures) and discriminant validity (e.g. client perceptions of therapist 
expertness, attractiveness, etc.) (Horvath, 1994; Tichenor & Hill, 1989).   As mentioned 
previously, confirmatory analyses of this measure indicate one general factor is the most 
parsimonious representation of the factor structure.  For this reason, mean item score will 
be used in all analyses. 
Swanson, Nolan, and Pelham AD/HD Checklist from the DSM-IV (SNAP-IV) 
The SNAP-IV was the primary AD/HD symptom scale used in MTA studies (The 
MTA Cooperative Group, 1999).  The SNAP-IV has shown adequate reliability and 
validity in psychometric studies (Swanson, 1992).  The 39-item SNAP-IV in this sample 
has good reliability (α = .94). Mother- and teacher-reported SNAP-IV will be utilized for 
the study.  The AD/HD composite score will be utilized as the outcome variable for all 
analyses, which is consistent with the analytical procedures used for the main MTA 
studies. 
Data Analysis 
Hierarchical Linear Modeling 
The present study uses hierarchical linear modeling, otherwise known as random-
coefficients regression or individual growth modeling (Francis et al, 1991; Raudenbush & 
Bryk, 2002).  This family of statistical procedures analyzes nested data (e.g., students 
within schools) or longitudinal data by generating growth curves (i.e., individualized 
change over time). The estimation procedures used in HLM are superior to random 
effects ANOVA and other longitudinal data approaches.  Each level-2 unit (e.g., multiple 
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time points nested within subjects) has a unique intercept and slope, and HLM models 
can also include data that has significant missing data.  This is in contrast to repeated 
measures ANCOVA, which can only fix a single growth parameter for all cases and 
typically requires no missing data.    
Allowing all available data to be included is a major advantage of HLM because 
maximizing the amount of subjects allowed leads to better estimates and increased 
statistical power.  Even subjects with only one time point can be included in longitudinal 
models.  Although these individuals would provide no information about within-person 
variation, HLM still incorporates these data into the estimates of fixed effects when 
appropriate (Singer & Willett, 2003). Another advantage over ANOVA procedures is that 
HLM handles irregularly spaced time points well.  Since time is modeled precisely in 
HLM, the data schedule does not have to be equally spaced.  Finally, HLM has the ability 
to accurately estimate variance and covariance components, even with unbalanced, nested 
data (Raudenbush & Bryk, 2002).  This gives the analyst the ability to decomposition the 
level-2 variation into within- and between-unit components, which cannot be done 
accurately with repeated measures ANOVA in unbalanced designs.   
The typical protocol for conducting HLM model comparisons will begin by 
generating an unconditional model, which is a model that lacks any level-2 predictors.  
Then, a model including level-2 predictors will be generated and then compared to the 
unconditional model.  Both of these models variance components will be estimated using 
full maximum likelihood.  Only full maximum likelihood deviance statistics can compare 
nested models that differ on both fixed and random components, as is planned in the 
current study.   
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In order to test our hypotheses regarding differential therapeutic alliance growth 
in different phases of treatment, a piecewise linear model will be used to generate 
separate slopes for the early and late phase of treatment.  Piecewise models have been 
used in other applications such in mental health services, where specifying particular 
phases of treatment better reflect individual trajectories or ease interpretation (Lambert, 
Wahler, Andrade, & Bickman, 2001).  These types of models have been used with 
success to model phenomena with distinct early and late longitudinal trajectories, such as 
patient response to HIV/AIDS medication (Littell, Milliken, Stroup, & Wolfinger, 1996).  
This study will test whether a piecewise model specifying “early” alliance development 
and “late” alliance development is more representative of the overall trajectory.  If so, the 
specified trajectories of alliance in “early” and “late” treatment will be compared to 
traditional summaries of therapeutic alliance (e.g., average TA) on their ability to predict 
treatment outcome in the MTA.   
Pattern-Mixture Model Analysis 
As mentioned previously, HLM can provide valid parameter estimates in the 
presence of missing data.  The caveat to this assertion is that the missing data must be 
considered ignorable nonresponse (Laird, 1988).  Ignorable nonresponse has been 
described as meeting Rubin’s (1976) missing at random (MAR) criteria, which is 
achieved when the factors contributing to the missing data can be attributed to both 
observed covariates and previous observed values of the missing data in question 
(Hedeker & Gibbons, 1997).  However, in cases where the MAR criteria may not be met 
due to missing data patterns, a class of models called pattern-mixture models are often 
used to address missing data in longitudinal designs (Hedeker & Gibbons, 1997; Little, 
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1995).  Subjects are grouped based on their missing data pattern and then the relative 
impact of these categorical classes of missing data can be tested.  When significant 
differences between different missing data patterns occur in outcomes (e.g., treatment 
completers show better treatment benefit than those that attrite), the pattern-mixture 
approach can model corrected estimates based on the missing data pattern of the sample. 
In order to determine if patterns of missing alliance data impacts alliance growth 
or eventual outcome, the pattern-mixture model approach will be utilized.  Although 
previous studies indicate that missing outcome data patterns have no effect on the major 
MTA outcome findings (e.g., The MTA Cooperative Group, 1999), similar analyses have 
not been conducted with patterns of missing alliance data.   It’s possible that certain 
missing data patterns (e.g., few valid alliance measurements collected) may be indicative 
of disengagement from the study procedures or recent alliance ruptures with the therapist.  
We will evaluate how the most common data patterns (e.g., missing vs. complete data) 
impact alliance, premature termination, and outcome.      
The procedures used to conduct a pattern-mixture analysis are similar to those that 
test models in standard hierarchical linear modeling.  The unconditional model will be 
compared to pattern-mixture models that correspond to subject-level missing data 
patterns.  Dummy codes reflecting these patterns will be modeled as level-2 predictors 
and compared with the unconditional model.  The variance components will also be 
estimated using full maximum likelihood to compare nested models.     
Assessing Treatment Dropout Using Survival Analysis  
Treatment dropout is also an important variable when assessing treatment 
engagement.  Survival analysis offers advantages over other forms of regression (e.g., 
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OLS regression, ANOVA) because of several properties specific to premature 
termination research (Corning & Malofeeva, 2004; Singer & Willett, 2003).  The ability 
for survival analysis to accurately account for censored data, time-varying covariates, and 
multiple end states simultaneously (e.g., premature termination, mutual termination, or 
censored termination) make this approach superior to traditional methods.  Survival 
analysis also provides more information than traditional methods because it can model 
both whether a premature termination occurred and when, which provide more powerful 
tests for covariates.    
The impact of treatment engagement covariates (e.g., therapeutic alliance growth) 
on premature dropout was analyzed using Cox regression survival analysis.  Similar to 
HLM conditional model comparisons, an estimate of a covariate’s goodness of fit is 
evaluated by the amount of additional variance it can account for over and above the 
unconditional model.  The goodness of fit test is distributed as a chi-square with degrees 
of freedom equal to the number of additional covariates being modeled.  After initially 
modeling premature termination with no predictors, several models with therapeutic 
alliance, patterns of missing data, and treatment group status will be entered as covariates 
will be generated.   
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CHAPTER III 
 
RESULTS 
 
Preliminary Analyses 
A total of 229 families that were involved in parent-training sessions were utilized 
based on the criteria described above.  Table 1 highlights the descriptive statistics, 
reliability and counts for number of waves caregiver alliance data by treatment group.  
The CWAI-S in this sample had acceptable reliability (α = .84) and acceptable numbers 
of observations per case for longitudinal analyses (approximately 2/3 of sample has 4 or 
more repeated measures per client).       
 
Table 1.  Descriptive data for the caregiver working alliance inventory item mean value 
and reflected log transformation. 
Highest # of 
Observations 
Measure n Mean SD Range 
Cronbach’s 
α 1 2 3 4+ 
 
CWAI-S 
 (item mean) 229 6.11 .52 4.14-7.00 .84 25 23 34 147 
 
Parent 
Training 118 6.14 .51 4.42-7.00 .84 16 9 22 71 
 Combined 111 6.09 .52 4.14-7.00 .84 9 14 12 76 
          
CWAI-S 
(transformed) * 0.25 .12 0.57-0.00 * * * * * 
 
Parent 
Training * 0.25 .12 0.55-0.00 * * * * * 
 Combined * 0.26 .11 0.57-0.00 * * * * * 
Note:  * indicates the same value in the transformed portion of the table as in the non-
transformed CWAI-S section  
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The CWAI-S was evaluated for normality.  The distribution was evaluated by 
using normal quantile plots to determine normality and identify outliers.  Outliers are 
problematic because they often have disproportionate influence on mean and variance 
estimates (e.g., Cohen, Cohen, West, & Aiken, 2003).  Examination of the distribution 
indicated a large negative skew with several outliers.  Tabachnik and Fidell (1989) 
provide formulas to transform skewness values to z scores.  Alliance ratings had 
significant skewness and kurtosis scores (i.e., all univariate z-transformed scores higher 
than 3.0 and 10.0 respectively), which indicated a large negative skew to both measures.  
In these cases, a reflected log transformation is strongly recommended (Tabachnik & 
Fidel, 1989).  The alliance ratings were transformed, which significantly improved its 
skewness and kurtosis.  As can be seen in Table 1, the reflected transformation reversed 
the interpretation of values (e.g., 0.0 = very high alliance after transformation).  Despite 
the transformation, there were still 6 cases that were considered outliers.  These cases 
were kept in the study, but they were windsorized.  Windsorizing recodes an outlier to a 
less extreme value, which is typically a z-score of 2.0 (Lipsey & Wilson, 2001).  This 
was done for all outliers.  
In order to assess early vs. late therapeutic alliance’s impact, the parent training 
sessions had to be categorized into “early” and “late” groups.  Data collection in the 
MTA data set had intended for therapeutic alliance on the “preferred visits” of parent 
training Session 4, 6, 12, 18, 24, and 27.  Figure 1 displays the historgram for therapeutic 
alliance data collected by session number.  As can be seen, data was collected most 
frequently on the preferred visits (e.g., 4, 6, 12, etc.) but at least some data was collected 
on each session.  To maximize power for all comparisons preferred visits 4, 6, and 12 
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were considered “early” sessions and visits 18, 24, and 27 were considered “late”.  In 
practice, subjects may have missing data on several of these preferred visit dates.  In 
order to systematically code for early and late sessions, session number was used to 
determine the early and late session categories.  Session 14 was selected because it 
approximated the midpoint of both the session number and cumulative frequency of the 
data collected.  Using this designation, 51% of the sample would be considered an 
“early” treatment session and 49% would be considered a “late” treatment session.  
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Figure 1.  Frequency of completed alliance data by session number. 
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The mother- and teacher-reported SNAP-IV data available from the primary 
caregiver alliance sample were also utilized.  Descriptive statistics for each reporter are 
included in Table 2.  All reliabilities are adequately high.  Exploratory analyses of each 
measure also indicate no problems with distribution or outliers.   
 
Table 2.  Descriptive data for the SNAP-IV total scale and subscales 
Highest # of 
Observations 
Measure n Mean SD Range 
Cronbach’s 
α 1 2 3 4+ 
 
Caregiver SNAP-IV 
(item mean) 229 1.31 .58 0.00-3.00 .94 2 8 16 203 
 Parent Training 118 1.42 .57 0.00-3.00 .93 0 7 10 101 
 Combined 111 1.19 .58 0.00-3.00 .95 2 1 6 102 
          
Teacher SNAP-IV 
(item mean) 216 1.27 .85 0.00-3.00 .93 3 5 31 177 
 Parent Training 112 1.41 .56 0.00-3.00 .93 0 4 21 87 
 Combined 104 1.11 .50 0.00-3.00 .92 3 1 10 90 
          
          
 
Caregiver Alliance Growth 
Inspection of the alliance slope trajectories prior to modeling indicated that a 
linear growth function would represent growth best across the entire duration of treatment.   
A two-level, unconditional hierarchical model of caregiver therapeutic alliance growth 
was generated.  The reason for modeling an unconditional growth model first is to 
determine on average if there is a significant slope, determine if growth and initial status 
should be considered fixed or random effects, and also to serve as a baseline for testing 
nested models.  Prior to modeling, the time variable (i.e., session number) was centered at 
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Session 2 because that was the earliest session an alliance rating was observed.  Table 3 
describes the findings for the unconditional growth model. 
The summary statistics for the unconditional model suggest that both the initial 
status and growth rate parameters are significant.  It should be noted that due to the 
reflected transformation described previously, a negative growth rate actually indicates 
increasing alliance.  The mean growth rate is significant and changing at -.003 logits 
(+.013 untransformed CWAI units) per session.  In untransformed units, this would 
indicate a change of 0.325 untransformed units across the span of the study.  Both initial 
status and growth also indicate significant variance, so both parameters can continue to 
be modeled as random parameters (i.e., initial status and slope that can be modeled 
uniquely to each subject).  One note of concern is that the overall reliability of the growth 
rate is at 0.21.  This indicates that only 21% of the growth of therapeutic alliance can be 
predicted by level-2 predictors.   
 
Table 3.  Linear growth model of alliance throughout treatment (unconditional model) 
Fixed Effect Coefficient SE t Ratio (df=228) p Value 
 
Mean initial status, β00 0.289 .01 30.74 <0.001 
Mean growth rate, β10 -0.003 .00 -6.50 <0.001 
     
Random Effect Variance df  χ2 p Value 
 
Initial status, r0i 0.01126 202 503.94 <0.001 
Growth rate, r1i 0.00001 202 247.82 <.015 
Level-1 error, eti 0.00882    
     
Random level-1 coefficient     
Initial status, π0i .54    
Growth rate, π1i .21    
     
Deviance Statistic (6) -1379.14   
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To test our hypothesis regarding the improved benefit of modeling an alliance 
piecewise model (i.e., early and late slope) versus one alliance slope for the entire study, 
the piecewise model was compared with the unconditional model.  Table 4 summarizes 
the unconditional model of the 138 subjects with sufficient data to model both an early 
and late slope, which is also displayed in Figure 2.  Inspection of Table 4 indicates that 
coefficients and variance components have similar values as in the larger sample.  The 
piecewise model was then generated and compared with the unconditional model of the 
smaller sample with sufficient data.    
 
 
Figure 2.  Linear Growth Model of Therapeutic Alliance by Training Session 
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Table 4.  Linear growth model of alliance over the course of treatment (unconditional 
model) for subjects with sufficient data to construct a piecewise growth model  
Fixed Effect Coefficient SE t Ratio (df=137) p Value 
 
Mean initial status, β00  0.292 0.011 25.59 <0.001 
Mean growth rate, β10 -0.003 0.001 -5.82 <0.001 
     
Random Effect Variance df  χ2 p Value 
 
Initial status, r0i 0.012 137 441.19 <0.001 
Growth rate, r1i 0.000 137 210.70 <0.001 
Level-1 error, eti 0.009    
     
Random level-1 coefficient     
Initial status, π0i .68    
Growth rate, π1i .34    
     
Deviance Statistic (6) -1024.82   
 
Table 5 displays the results of the alliance piecewise model.  Inspection of the 
piecewise model parameters indicates that the early slope was found to be significant, 
which is in contrast to the nonsignificant overall slope of the late sessions.  The variance 
components of both early and late slope were significant, indicating each have significant 
random effects.  As predicted, the early slope is both more steep and variable than the 
slope later in treatment.    Descriptively, this indicates that alliance fluctuations are larger 
early in treatment, but then become more gradual (i.e., no significant change on average) 
and less variable later in treatment.  When compared with the unconditional model, the 
piecewise model predicts a statistically significant amount of additional variance (i.e., 
13.4% of  Level-1 variance) to justify the more complicated, piecewise model (χ2(4) = 
16.76, p < .01).  
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Table 5.  Linear piecewise model of growth of alliance over the course of treatment (early 
slope and late slope) 
Fixed Effect Coefficient SE t Ratio (df=137) p Value 
 
Mean initial status, β00 0.310 0.01 23.75 <0.001 
Mean early growth 
rate, β10 -0.007 0.001 -4.34 <0.001 
Mean late growth rate, 
β10 -0.002 0.001 -1.85 0.067 
     
Random Effect Variance df  χ2 p Value 
 
Initial status, r0i 0.01375 137 328.66 <0.001 
Early growth rate, r1i 0.00010 137 206.96 <0.001 
Late growth rate, r2i 0.00003 137 219.04 <0.001 
Level-1 error, eti 0.00741    
     
Random level-1 coefficient     
Initial status, π0i .55    
Early growth rate, π1i .30    
Late growth rate, π2i .34    
     
Deviance Statistic (10) -1041.580083   
 
Caregiver Alliance Growth Relationship to Outcome 
Using the sample with sufficient data to model both an early and late therapeutic 
alliance slope, the relationship between outcome and fluctuations in therapeutic alliance 
was evaluated.  Using the residual file from the generated piecewise therapeutic alliance 
model, the respective early and late slope was calculated by adding the ordinary least 
squares residual of the subject to the fitted model value.  Traditional conventions to 
summarize therapeutic alliance were also utilized including average overall TA, average 
early TA, and average late TA. 
The distributions for early alliance slope, late alliance slope, and the conventional 
TA summary variables were all evaluated for normality.  Significant outliers were 
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identified for both of the slope variables (i.e., three and five, respectively).  These outliers 
were truncated by windsorizing them.   All distributions were then assessed for normality 
using both Kolmogorov-Smirnov and Shapiro-Wilk tests (Chakravarti, Laha, & Roy, 
1967; Shapiro & Wilk, 1965).  All were non-significant indicating the distributions 
reasonably adhere to a normal distribution for their respective sample size.   
The relationship between therapeutic alliance growth and outcome was then 
evaluated.  The primary outcome variable for the MTA, the SNAP-IV AD/HD composite 
score, was utilized as the dependent variable as reported by both caregivers and teachers.  
As was practiced in the primary MTA analyses, a log transformation was performed on 
the Level-1 time variable due to the curvilinear trajectory of outcome growth.  The 
practice of transforming curvilinear trajectories with a log transformation aids both 
estimating parameters and interpretation of the coefficients (Cohen, P., Cohen, J., West, 
S., & Aiken, L., 2002). 
Therapeutic alliance growth was first evaluated with the caregiver-reported 
AD/HD composite score up to the end of the treatment phase (i.e., 14-month timepoint). 
Table 6 summarizes the unconditional model for caregiver-reported outcome with a log-
transformed Level-1 time covariate.  Inspection of the growth coefficient indicates that 
the slope is significant (i.e., AD/HD symptoms improve over time).  The variance 
components for both growth and initial status are also significant, justifying their model 
specification as random effects.    
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Table 6.  Unconditional model for Caregiver-reported SNAP-IV AD/HD Composite over 
the course of treatment (i.e., through 14-month timepoint) 
Fixed Effect Coefficient SE t Ratio (df=137) p Value 
 
Mean initial status, β00 1.89 0.06 33.17 <0.001 
Mean SNAP growth 
rate, β10 -0.33 0.02 -15.89 <0.001 
     
Random Effect Variance df  χ2 p Value 
 
Initial status, r0i 0.301 137 420.57 <0.001 
Growth rate, r1i 0.022 137 222.47 <0.001 
Level-1 error, eti 0.151    
     
Random level-1 coefficient     
Initial status, π0i .67    
Growth rate, π1i .38    
     
Deviance Statistic (6) 860.21   
 
The effect of treatment group (i.e., Combined Treatment vs. Parent Training Only) 
on the AD/HD composite score was then modeled.  Table 7 summarizes the effect of 
treatment group on caregiver-reported outcome at the end of the treatment phase.  When 
compared with the unconditional model, the model including treatment group predicts a 
significant amount of additional variance to justify its inclusion (χ2(1) = 30.72, p < .001).    
Consistent with the major findings of the MTA study, the combined treatment group 
improved at a significantly faster rate when compared to parent training alone.  These are 
illustrated in Figure 2.    
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Figure 3.  14-month caregiver-reported AD/HD symptoms by treatment group 
 
Both early and late therapeutic alliance slope was then evaluated by entering it in 
the model that included treatment group.   Table 8 summarizes the model with treatment 
group, early TA slope, and late TA slope. When the TA slopes were entered, they 
werefound not to predict any additional variance χ2(2) = 0.86, p < .65).  Similar null 
findings were found when average early TA (χ2(1) = 0.32, p < .57), average late TA 
(χ2(1) = 0.08, p < .78),  and average overall TA (χ2(1) = 0.02, p < .89) were entered 
respectively with a model including treatment group.  It appears that, contrary to our 
hypotheses, that therapeutic alliance did not contribute to predicting eventual treatment 
outcome over and above participation in combined treatment. 
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Table 7.  14-month caregiver-reported AD/HD composite model including treatment 
group  
Fixed Effect Coefficient SE t Ratio (df=137) p Value 
 
Mean initial status, β00 1.89 0.06 33.23 <0.001 
Mean SNAP growth 
rate, β10 -0.33 0.02 -17.25 <0.001 
Combined treatment, 
β11 -0.18 0.03 -5.90 <0.001 
     
Random Effect Variance df  χ2 p Value 
 
Mean initial status, β00 0.300 137 419.66 <0.001 
Growth rate, r1i 0.014 136 189.39 0.002 
Level-1 error, eti 0.152    
     
Random level-1 coefficient     
Initial status, π0i .67    
Growth rate, π1i .27    
Deviance Statistic (7) 829.490318    
     
Variance explained 
 
Var (π0i) Var (π1i)   
Unconditional N/A 0.02232   
Conditional on 
Treatment N/A .01356 
  
Proportion of Variance 
Explained N/A 39.2 
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Table 8.  14-month caregiver-reported AD/HD composite model including treatment 
group and piecewise alliance slopes 
Fixed Effect Coefficient SE t Ratio (df=137) p Value 
 
Mean initial status, β00 1.89 0.06 33.21 <0.001 
Mean SNAP growth 
rate, β10 -0.33 0.02 -17.29 <0.001 
Combined treatment, 
β11 -0.18 0.03 -5.77 <0.001 
Early TA Slope,  
β12 -0.55 0.90 -0.61 0.55 
Late TA Slope,  
β13 0.70 1.88 0.37 0.71 
     
Random Effect Variance df  χ2 p Value 
 
Mean initial status, β00 0.300 137 419.64509 <0.001 
Growth rate, r1i 0.013 134 187.46679 0.002 
Level-1 error, eti 0.152    
     
Random level-1 coefficient     
Initial status, π0i .67    
Growth rate, π1i .27    
     
Deviance Statistic (9) 828.625328   
    
 
Therapeutic alliance was also found to not be related to caregiver-reported 
outcome when long-term effects were evaluated (i.e., 24-month time point).  Consistent 
with the previous findings, the model including treatment group accounted for a 
significant amount of additional variance (χ2(1) = 18.07,  p < .001) and clients in the 
combined treatment group improved at a faster rate.  However, a model with treatment 
group, and both TA slope parameters did not account for additional variance when 
compared with the model with only treatment group (χ2(2) = 0.78, p < .68).  The 
traditional TA conventions of average early TA (χ2(1) = 0.00, p < .99), average late TA, 
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and average overall TA (χ2(1) = 0.47, p < .49) also failed to account for additional 
variance when entered in model including treatment group.  It appears that therapeutic 
alliance is not related to outcome on any of the primary caregiver-reported outcome 
measures. 
Therapeutic alliance growth was also evaluated using the teacher-reported 
AD/HD composite of the SNAP-IV in a similar fashion.   Beginning with the data 
available up to the end of treatment (14-month timepoint), treatment group was entered 
first and yielded a model that accounted for a significant amount of additional variance 
when compared to the unconditional model (χ2(1) = 14.33, p < .001).  When the TA 
slopes were then added to the model with treatment group, they did not account for a 
significant amount of variance (χ2(2) = 2.10, p < .35).  Similar non-significant findings 
were found for average overall TA (χ2(1) = 0.15, p < .70), average early TA (χ2(1) = 
0.98, p < .32), and average late TA (χ2(1) = 0.11, p < .74).  Similar to the primary 
caregiver-reported outcome measures, therapeutic alliance did not predict outcome over 
and above treatment assignment at the end of treatment (14-months).  
Some significant relationships between outcome and therapeutic alliance did 
emerge when the teacher-reported long term outcomes were included.  As before, 
treatment group was found to be a significant predictor of treatment outcome when 
compared to the unconditional model (χ2(1) = 15.81, p < .001).  When the TA slopes 
were added to the model including treatment group, the new model including the TA 
slopes accounted for a significant amount of variance (χ2(2) = 6.85, p < .03), and it is 
summarized in Table 9.  Inspection of Table 9 indicated that the Early TA slope 
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parameter was not significant, and so it was removed from the model.  The model 
including only treatment group and Late TA slope was then generated but not significant 
(χ2(1) = 3.48, p < .06).  Similar to all previous outcome analyses, the traditional TA 
conventions of average TA (χ2(1) = 0.08, p < .78), average early TA (χ2(1) = 0.61, p < 
.44), and average late TA (χ2(1) = 1.84, p < .17)  were all non significant.  Similar to the 
other analyses, the traditional summaries of therapeutic alliance did not predict outcome 
in the 24-month teacher-reported outcome measures.  However, entering both early and 
late therapeutic alliance slope did predict treatment outcome over and above treatment 
assignment (i.e., 15.1% explained error variance).  However this trend did not hold once 
early alliance slope was removed due to lack of a significant Early TA slope coefficient.   
Pattern Mixture Analysis 
The degree that therapeutic alliance missing data patterns affects outcomes were 
evaluated using pattern mixture analysis procedures.  In order to accurately evaluate 
patterns of missing data, a dummy coding strategy was utilized to reflect different 
patterns of missing data.  Subjects were divided by these missing data patterns and 
entered as level-2 variables.  As mentioned previously, therapeutic alliance ratings had 
six “preferred” timepoints where alliance data was to be collected (i.e., Sessions 4, 6, 12, 
18, 24, 27).  Due to the number of permutations of missing data in six timepoints (i.e., 26 
= 64 separate patterns), the groups were combined to early, middle, and late.  From these 
major categories, the frequency table for existing data patterns was generated and is 
displayed in Table 10.   
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Table 9.  24-month caregiver-reported AD/HD composite model including treatment 
group and piecewise alliance slopes 
 
Fixed Effect Coefficient SE t Ratio (df=133) p Value 
 
Mean initial status, β00 1.95 0.07 29.20 <0.001 
Mean SNAP growth 
rate, β10 -0.37 0.02 -15.20 <0.001 
Combined Treatment, 
β11 -0.12 0.03 -3.88 <0.001 
Early TA Slope,  
β12 1.83 1.07 1.72 0.088 
Late TA Slope,  
β13 4.67 1.77 2.65 0.010 
     
Random Effect Variance df  χ2 p Value 
 
Mean initial status, β00 0.285 133 255.54 <0.001 
Growth rate, r1i 0.015 130 165.06 0.02 
Level-1 error, eti 0.331    
     
Random level-1 coefficient     
Initial status, π0i 0.475    
Growth rate, π1i 0.185    
     
Deviance Statistic (9) 1185.223060   
    
Variance explained 
 
Var (π0i) 
 
Var (π1i)   
Conditional on 
Treatment N/A 0.01750 
  
Conditional on 
Treatment and 
Alliance Slope N/A 0.01485  
 
Proportion of Variance 
Explained N/A 15.1  
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Table 10.  Frequency table of missing data patterns over early, middle, and late parent-
training sessions  
Missing Data Pattern Frequency Percentage 
 
Observed./Observed./Observed. 121 52.8 
Observed./Observed./Missing. 26 11.4 
Observed./Missing./Missing. 24 10.5 
Missing./Missing./Observed. 20 8.7 
Missing./Observed/Observed 17 7.4 
Observed/Missing./Observed 16 7.0 
Missing/Observed/Missing. 5 2.2 
 
Few missing data patterns had enough data to warrant separate analyses for each 
category.  When this is the case, Hedecker & Gibbons (1997) recommend testing missing 
data patterns that both incorporate adequately represented categories and can model 
complete/incomplete data patterns.  For this reason two major comparisons were utilized 
that represented the most frequent missing data patterns.  The first compared those with 
complete data in all three phases in treatment to those with any missing data (i.e., 
complete vs. incomplete data).  This comparison included all data available and 
compared groups of relative equal groups (i.e., Completers = 53% vs. Non-completers = 
47%).  The second pattern that utilizes the most frequent missing data patterns compares 
completers vs. those that begin initial data collection and then subsequently drop out of 
all further alliance data collection.  This analysis compared the three most common 
missing data patterns and 75% of the sample.  This comparison also highlights our 
hypotheses regarding the importance of early alliance and subsequent dropout could 
serve as a proxy for low treatment engagement.  Hedecker & Gibbons describe this 
comparison as a monotone pattern of dropout and is represented by two dummy coded 
variables.    The dummy coding strategies for both the incomplete and monotone coding 
schemes are illustrated in Appendix II.    
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The impact of various patterns of missing alliance data was tested on several 
outcome variables.  Similar to our previous procedures, an unconditional model must first 
be generated before the pattern mixture models can be compared to it.  For comparing 
subjects with incomplete data collection vs. complete data collection, the full 
unconditional model for therapeutic alliance displayed in Table 3 was used.  Using the 
“incomplete” coding strategy illustrated in Appendix 2, the impact of a subject having 
incomplete data was tested on their overall therapeutic alliance growth.  The pattern 
mixture model was found to be nonsignificant, suggesting that the effect of having 
incomplete data does not significantly alter the growth or intercept of therapeutic alliance 
(χ2(2) = 0.53, p < .77).  Similarly using the “monotone” coding strategy, no significant 
differences were found on alliance development between subjects with complete data 
versus initial participators who “dropout” in future waves (χ2(4) = 4.22, p < .38).   
Similar procedures tested the impact of missing alliance data on treatment 
outcome.  Consistent with the lack of effects missing data has on alliance growth, missing 
data patterns had no significant impact on outcome.  When using the incomplete coding 
strategy, missing data patterns had no effect on either caregiver-reported 14-month (χ2(2) 
= 2.26, p < .33) or 24-month outcome (χ2(2) = 1.54, p < .47).  Incomplete data also had 
no effect for 14-month (χ2(2) = 0.66, p < .72) and 24-month (χ2(2) = 0.28, p < .87) 
teacher-reported outcome.  When using the monotone coding strategy (i.e., initial 
participators who dropout in all subsequent data collection), no effects were found on 
teacher-reported (14-month- χ2(4) = 1.50, p < .83 ; 24-month-  χ2(4) = 3.53, p < .47) or 
 43
caregiver-reported (14-month- χ2(4) = 1.21, p < .88 ; 24-month-  χ2(4) = 3.00, p < .56) 
outcome. 
It appears that patterns of missing therapeutic alliance data do not predict either 
therapeutic alliance growth or subsequent clinical outcome.  Although hypothesized to be 
a proxy for treatment engagement, it did not predict outcome on either caregiver- or 
teacher-reported outcome measures.   
Survival Analysis 
 The effect of treatment engagement variables on premature termination was 
evaluated using survival analysis procedures.  In particular, Cox (1972) regression 
procedures were used to generate both the survival functions and test the goodness of fit 
of added covariates to the baseline hazard function.  Because Cox regression assumes that 
time is on a continuous scale, the number of days since baseline was used as opposed to 
assessment point for the time variable.  Also due to the skew in the time distribution 
typically found in survival analysis, time was modeled after a log transformation.  Figure 
2 illustrates the baseline cumulative survival function.  To ease interpretation, the x-axis 
was transformed back to raw number of days since baseline.  Inspection of the function 
indicates that a gradual decline in treatment participation occurs during the 3-month 
(median= 104 days) and 9-month time points (median = 229 days).  A more drastic 
decline occurs at the 14-month timepoint (median = 412 days), where a larger proportion 
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Figure 4.  Cumulative survival function of treatment dropout 
Covariate analyses were conducted using the primary therapeutic alliance 
variables, missing data patterns, and treatment assignment.  Each static covariate (i.e., 
average overall alliance, alliance missing data pattern, and treatment assignment) was 
tested separately by entering it as a predictor and comparing the difference in goodness of 
fit , which is distributed as a chi-square with one degree of freedom.   In addition, alliance 
slope (early and late) and average slope (early and late) were modeled as time-varying 
covariates.  Based on the concordance between parent-training session 14 (i.e., the 
midpoint of the treatment protocol) and the corresponding outcome measurement point, 
the time-varying covariate was considered “early” until the 9-month outcome 
measurement point when the covariate became “late”.   
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Figure 5.  Cumulative survival by treatment group 
The results of covariate effects on survival are displayed in Table 11.  Consistent 
with previous analyses, none of the alliance variables or missing data patterns were 
related to premature termination.  The only significant predictor of premature termination 
was treatment assignment.  Figure 3 illustrates the survival function by treatment group.  
Once again, in contrast to treatment group assignment, it appears that engagement 
variables are not related to outcome in the MTA data set.    
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Table 11.  Cox regression analyses with covariates predicting premature termination.   
Covariate B SE χ2dif p Value Effect Size (r)
 
Treatment Group -2.64 0.60 38.39 <0.001 0.41 
 
Overall Average TA 0.48 1.39 0.12 0.73 0.02 
 
Early Average TA .08 1.45 0.00 0.96 0 
 
Late Average TA .03 1.54 0.00 0.99 0 
 
Early TA Slope -10.08 12.94 0.61 0.44 0.06 
 
Late TA Slope 12.78 21.50 0.35 0.56 0.05 
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CHAPTER IV 
 
DISCUSSION 
 
This study generated several findings related to therapeutic alliance and outcome: 
1. Therapeutic alliance is volatile within-clients and has different trajectories in 
early versus late treatment.  This brings into question the utility of traditional 
means of summarizing therapeutic alliance such as average overall alliance 
and one-session snapshots of alliance over phases of treatment. 
2. Assignment to the combined treatment (i.e., medication management and 
behavioral treatment) significantly predicted therapeutic outcome.  
Inconsistent with our hypotheses, therapeutic alliance did not consistently 
predict treatment outcome over and above treatment assignment. 
3. Patterns of missing therapeutic alliance data, hypothesized to be a proxy for 
overall treatment engagement, was not predictive of therapeutic alliance 
growth or treatment outcome. 
4. Premature treatment dropout, as analyzed using survival analysis, was only 
predicted by treatment group assignment.  Treatment engagement variables 
such as therapeutic alliance and missing alliance data patterns did not predict 
premature treatment termination.     
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This study incorporated several different statistical techniques to investigate the 
role of longitudinal treatment engagement on treatment outcome.  The treatment 
engagement literature, with a few recent exceptions, has not addressed adequately the 
role that longitudinal changes in constructs such as therapeutic alliance can affect 
eventual treatment outcomes.  As opposed to the majority of studies that use one-session 
snapshots to represent stretches of treatment, this study utilized piecewise HLM growth 
models to represent therapeutic alliance trajectories representative of the larger course of 
treatment engagement over time. 
This study utilized the Multimodal Treatment Study of Children with AD/HD to 
address the role of longitudinal treatment engagement for several reasons.  First, the 
MTA systematically collected therapeutic alliance data up to seven times over the course 
of a 14-month treatment span.  There is no other published study that parallels the scope 
or frequency of therapeutic alliance data collection over such a long period of treatment.  
Second, the MTA collected therapeutic alliance data from the most commonly utilized 
measure (i.e., WAI).  The fact that this study utilizes the state-of-the-art measure adds to 
the generalizability of the findings.  Third, the study also was a first to evaluate the role 
that caregiver therapeutic alliance could have on clinical outcome of child mental health 
services.  The role that caregivers play in both the financing and execution of child 
treatment plans are well documented (Weisz & Jensen, 1999).  Therefore, the impact of 
the caregiver’s bond to the therapist on outcome is important to evaluate. 
First, this study described the pattern of therapeutic alliance growth during the 
course of therapy.  The theories describing therapeutic alliance development typically 
conceptualize alliance to be a volatile process, particularly in the early stage of treatment.  
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Therefore for this sample, it was hypothesized that higher fluctuations in therapeutic 
alliance (i.e., more drastic growth) and the overall volatility (i.e., higher variability) 
would be most likely found in the early stage of treatment.  Once the therapeutic alliance 
is established and the client internalizes the treatment rationale in later stages, the alliance 
should stabilize (i.e., small subsequent alliance growth) and the frequency of treatment 
alliance ruptures should dissipate (i.e., less variability).   
In order to adequately describe the possibility that growth may be different or 
more variable in different phases of treatment, a therapeutic alliance piecewise growth 
model was generated.  When the piecewise model was compared to a single slope model, 
the findings were consistent with all of the initial hypotheses.  First, the piecewise model 
represented therapeutic alliance growth significantly better than a typical linear growth 
model.  This suggests that alliance growth could vary significantly depending on the 
phase of treatment.   Second, alliance growth exhibited more drastic growth trends early 
in treatment.  Inspection of the alliance growth coefficients indicated that alliance 
generally increased during the early phase of treatment but then typically leveled off (i.e., 
no significant growth) during the late phase of treatment.  Finally, the variability of 
alliance was more pronounced in early treatment.  The variance in early treatment was 
also larger than in late treatment suggesting that the volatility also decreased as treatment 
progressed. 
These descriptive findings from the alliance piecewise growth model can be 
explained by either theoretical or methodological factors.  Most of the theories relevant to 
therapeutic alliance suggest that treatment engagement would be the most volatile early 
in the treatment process.  For example, the phase model for psychotherapy describes that 
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a client seeking treatment must first be socialized to the rationale and procedures of 
treatment in the early phase of remoralization.  During this phase the client must reframe 
their mental condition and begin to trust the therapist as an agent for change.  Due to the 
number of factors that could affect the outcome of this initial phase (e.g., the client’s 
motivation to change, the match between pretreatment expectancies and the therapist’s 
treatment rationale, the therapist’s ability to persuade the client), the period would be 
expected to be highly volatile and could perhaps lead to the most client-initiated 
unilateral treatment termination.  The descriptive picture of MTA therapeutic alliance 
growth would be consistent with this theoretical explanation.  However, the 
methodological nuances of the MTA sample cannot be entirely ruled out.  The 
distribution of therapeutic alliance ratings was skewed, indicating that a majority of 
caregivers reported high alliance with their therapist throughout the study.  As therapeutic 
alliance increased during the study, the already high alliance may have exhibited a ceiling 
effect in late sessions for some participants.  In fact, 17% of the sample that had a late 
session at all (i.e., 31 of 186) had the highest score possible on their last recorded late 
session.  However, despite the overall high alliance ratings in late sessions, 42% of the 
late TA slopes in the piecewise model were decreasing.  These findings indicate that 
although overall high TA led to truncation and ceiling effects in a portion of the sample, 
nearly half of the participants were demonstrating decreasing alliance in late treatment.  
This indicates that although alliance growth is affected by consistently high alliance 
ratings, ceiling effects cannot completely explain the descriptive findings. 
The second question this study addressed was the relationship between 
therapeutic alliance growth and treatment outcome.  In addition to evaluating the 
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predictive utility of alliance growth, the study also evaluated how alliance growth 
compares to the literature regarding traditional methods of summarizing therapeutic 
alliance.  Consistent with previous studies, the average early, late, and overall alliance 
were all included as possible predictors of treatment outcome.  It was hypothesized that 
all therapeutic alliance indicators would be related to therapy outcome, but therapeutic 
alliance growth would be a better predictor due to its ability to represent treatment 
engagement trends.  Furthermore, early alliance growth was hypothesized to be the most 
predictive indicator of eventual outcome, because it represented the alliance trend during 
the relationship-building phase of treatment. 
Contrary to our hypotheses, every therapeutic alliance indicator failed to predict 
treatment outcome over and above the effect of treatment group.  In both caregiver- and 
teacher-reported outcome, none of the therapeutic alliance indicators significantly 
predicted outcome.  Similar results were found in both 14-month and 24-month outcome.  
There was a trend for late therapeutic alliance growth to be a significant predictor over 
and above treatment assignment in the 24-month teacher reported data.  However, little 
weight can be attributed to this finding due to the number of a priori comparisons 
conducted. 
The third major research question of this study was the degree that patterns of 
missing alliance data could predict alliance or treatment outcomes.  Although therapeutic 
alliance ratings can directly assess a client’s level of treatment engagement, this study 
hypothesized that families who participate sporadically in alliance data collection may 
also not be engaging in the overall treatment.  Conceptualizing participation in alliance 
data collection as a proxy to therapeutic alliance itself, caregivers who participate in most 
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or all data collection procedures were expected to have higher alliances as well as better 
outcomes.  Two different coding strategies were used to assess the impact of missing data 
as outlined by Hedecker & Gibbons (1997).  The “incomplete” coding scheme directly 
compared those who completed alliance data in all phases of treatment to those who 
missed any along the way.  Although this can illustrate the general impact of missing data 
on outcome, it does not address our hypotheses regarding the impact of dropout after 
initial early treatment engagement.  If clients participate initially and then subsequently 
dropout, it is hypothesized that these clients will have initially poor alliance (i.e., in early 
treatment) and subsequent poor outcome. 
As with the ratings of alliance, the patterns of missing alliance data were not 
related to outcome.  For both the incomplete and monotone coding schemes, missing data 
patterns were related to neither alliance nor outcome.  Although it may have been the 
case that missing alliance data collection could be a proxy for poor alliance (particularly 
in this generally high alliance sample), the results do not support our hypotheses.  
Perhaps other proxies for treatment engagement may be more related to alliance 
development and outcome.  Proxies such as parent-training session attendance or 
medication management adherence (e.g., pill counts, prescription records) may be better 
indicators of treatment engagement because they are directly related to participation in 
specific components of treatment. 
Our final research question investigated whether treatment engagement variables 
or treatment selection was related to premature dropout.  Similar to our previous research 
questions, it was hypothesized that those with low overall therapeutic alliance, declining 
alliance growth, and poor alliance measurement attendance would be associated with 
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premature termination.  Since combined treatment was found to a more effective 
treatment for AD/HD, the study also hypothesized that treatment group was related to 
outcome.  It was argued that not being exposed to the most effective treatment would be 
similarly related to premature termination as treatment engagement.     
Consistent with our previous analyses, none of the therapeutic alliance indicators 
predicted premature termination.   The only significant predictor was treatment group.  
Overall, not a large portion of the sample prematurely dropped out (40 out of 229).  
However, 38 of those who did dropout were from the Parent Training Only treatment 
group.  At first glance, it would seem the difference between premature treatment 
termination between the combined and parent-training groups is vastly different.  
However, it should be noted that the MTA defined dropout as both participants who 
literally dropped out of the study and/or participants who crossed treatment arms (i.e., 
began another treatment that was not initially assigned).  Although the distinction 
between these types of “dropout” were not coded directly, it was systematically easier to 
dropout of the parent training only group because adding any additional treatment 
constituted dropping out of this group.  In contrast, nothing could be added to the 
combined treatment group.  Nevertheless, significantly more parent-training only 
participants dropped out, most likely due to experiencing less benefit from the parent 
training only treatment.  When comparing these results with the lack of association with 
therapeutic alliance variables, it is interesting to speculate why alliance was not related to 
any outcome in most comparisons.     
Despite the large literature indicating that therapeutic alliance is a significant 
predictor of outcome, some aspects particular to the MTA study may have contributed to 
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alliance’s non-findings.  For example, this is the first outcome study to date that has 
evaluated therapeutic alliance’s relationship to outcome of AD/HD treatment.  There may 
be factors specific to AD/HD (e.g., primarily a neurological disorder) that may stymie a 
strong therapeutic relationship from having additional benefit over and above highly 
effective treatments.  Just as it would be unreasonable to suggest that having a strong 
bond with your neurosurgeon could improve the outcome of having a tumor over and 
above the latest surgical procedures, the same may be the case for disorders that are 
primarily not affected by psychological factors such as social influence.   
The fact that the most effective treatment for AD/HD is a combination of 
medication and psychological treatment could also be related to alliance’s non-findings.  
Although alliance has been found to be related to outcome in pharmacotherapy trials 
before (e.g., Krupnick, Sotsky, Simmens, & Moyer, 1996), alliance may not be adequate 
to predict outcome consistently in interventions that require little more of the client than 
take medication daily.  Alliance may be a better predictor of outcome in interventions 
that require more time-consuming/involving therapeutic tasks (e.g., doing daily mood 
grids, thought records several times a day).  It could also be a better predictor in 
interventions that have a larger variability in treatment adherence.  For example, a client 
with adequate alliance could attend weekly sessions to vent but do very little outside the 
therapy hour to address their issue.  However, a highly engaged client may journal, 
complete, daily mood records, implement the therapist’s suggestions for behavior change, 
or other activities in addition to attending the treatment session.  For these reasons, 
alliance may be a better predictor of treatment outcome in interventions where the 
variability in exposure to a treatment’s “specific effects” is greater or involve large 
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amounts of time/energy to be compliant with the treatment.  Even among medication 
treatment regimens, treatment engagement variables may be better related to outcome in 
regimens that require extensive monitoring/dosing (e.g., diabetes control) than taking a 
dose once or twice a day, as is typically the case in AD/HD treatment. 
Another possible factor for the non-findings specific to the MTA data was that 
therapeutic alliance was reported by the client’s caregivers.  The MTA study is the first 
study to date that directly addresses the role of caregiver therapeutic alliance on client 
outcome.  Although there is previous literature citing the importance of caregiver 
therapeutic alliance in child studies, most of these studies were conducted using 
retrospective surveys or were theoretical papers.   Several factors could explain why 
caregiver therapeutic alliance would not be as predictive of outcome as it is in typical 
mental health treatment modalities.  First, although the “therapy” is caregiver-centered 
the eventual outcome is based on their child’s symptoms.  It could be that the therapeutic 
relationship that the caregiver develops with the therapist may be too far removed to 
helping with the child’s symptoms.  Theories relevant to alliance’s impact on outcome 
describe how the therapeutic relationship is important to remoralizing the client by 
reframing their problems in the context of the therapist’s treatment rationale and instilling 
hope (e.g., remoralization) (Frank & Frank, 1993; Howard et al, 1993).  Motivating the 
client through processes such as remoralization may improve symptoms via positive 
expectancies or other psychological effects that may be difficult to transfer to an 
individual not directly involved in the therapeutic process.    
Finally, therapeutic alliance’s inability to predict outcome or premature 
termination may be related to the lack of variability in the MTA alliance data.  As 
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mentioned previously, the majority of caregivers in the MTA sample had high alliances 
with their therapist.  It may be that high overall alliance ratings should be expected in 
efficacy trials that include highly trained clinicians using state-of-the-art treatments with 
intense supervision.  In fact, high alliance ratings in randomized control trials are not 
uncommon, particularly with self-report alliance measures (Kendall et al, 1997; Schelef, 
Diamond, Diamond, & Liddle, 2005).  However, the fact remains that truncated 
distributions leading to ceiling effects limit the ability to detect true associations between 
variables (Cohen, P., Cohen, J., West, S., & Aiken, L., 2002).  Further troubling is the 
fact that families who did not participate in alliance data collection had poorer treatment 
outcomes on teacher-reported measures.  Having a more representative sample from all 
families involved in treatment may have increased the power enough to detect differences.        
The following study evaluated the impact of longitudinal therapeutic alliance 
development on outcome and other treatment engagement variables.  Based on the 
available data using appropriate longitudinal analytic techniques, caregiver-reported 
therapeutic alliance does not appear to be strongly related to treatment outcome for child 
AD/HD treatment.  Although this study advanced the scope of how alliance can be 
investigated in child studies, much more work is needed to determine the impact that 
treatment engagement variables affect outcome.  This study utilized hierarchical linear 
modeling that can flexibly model sample trends despite missing data or irregularly spaced 
time points.  Although this approach is flexible to account for missing data, samples that 
can minimize the amount of missing data and include additional treatment engagement 
variables can address more specific theoretical and methodological longitudinal questions 
than in the current study.   
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One way to advance alliance literature would be to actively test competing 
theories why therapeutic alliance is related to treatment outcome.  For example, there are 
two competing hypotheses explaining alliance’s relationship to outcome based on the 
general- vs. specific-effects debate (Feeley, DeRubeis, & Gelfand, 1999; Wampold, 
2001).  One main theory explains that therapeutic alliance is a necessary predicate of 
future treatment benefit, and improvement in symptoms/functioning can be predicted by 
previous gains in the therapeutic relationship (e.g., Klein et al, 2003; Frank & Frank, 
1993).  A competing theory explains that high therapeutic alliance is based on 
experiencing prior symptom relief based on the specific effects of treatment (e.g., CBT 
techniques).  Although these competing theories have been actively tested in previous 
studies (e.g., DeRubeis, Brotman, & Gibbons, 2005), these studies have used OLS 
regression techniques that are simply not adequate to address these longitudinal questions.  
A possible future study could utilize structural equation modeling (SEM) that can 
specifically test the two competing models using cross-lag designs.  However, due to 
SEM requirement of equal time intervals and complete data, this study may be more 
likely to be conducted in treatment efficacy trials than in community settings.   
Another way to move the literature forward is to stop focusing exclusively on 
therapeutic alliance and expand the scope of treatment engagement to other variables.  
Although alliance has been found to be a key predictor of outcome, it is only one 
indicator of treatment engagement.  Specifically, alliance is a summary of attitudes 
toward the therapist and treatment procedures.  But it does not inform about what a 
clients does in the context of the therapy procedures.  Adding engagement variables such 
as homework completion rates or weekly session attendance in addition to regular 
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therapeutic alliance ratings may represent a better indication of overall treatment 
engagement.  Additional variables such as pretreatment expectancies have also been 
getting increased attention (e.g., Dew & Bickman, 2005).  Promising research in this field 
suggests that therapeutic alliance mediates the relationship between expectancies and 
eventual therapeutic outcome (Abouguendia, Joyce, Piper, & Ogrodniczuk, 2004).  
Investigating further the relationship between pretreatment variables, alliance, and 
eventual outcome may lead to better understanding of the longitudinal processes that 
affect outcome.     
A final approach to improving the therapeutic alliance literature is to develop 
better measures that have more suitable distributions for analyses. The distributions for 
both the therapeutic alliance ratings were both highly skewed and positive.  More 
attention needs to be focused on developing alliance scales that are less likely to have 
ceiling effects (i.e., more “difficult” in content).  Generating items that may tap into 
higher degrees of alliance (e.g., “I implement what my therapist challenges me to do 
everyday”) may further differentiate alliance on the high side.  New measurement 
methods, such as item response theory, can be implemented to determine items that may 
discriminate between individuals with moderate alliance and high alliance (Embretson & 
Reise, 2000).  By continuing to use measures with truncated variance, researchers may be 
generating spurious findings and attenuated correlations between alliance and other 
variables.    
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APPENDIX A 
 
CONSTRUCTING PIECEWISE MODELS 
Piecewise models are useful to model nonlinearity in data.  Although a linear 
model seems the most parsimonious when looking at the entire span of treatment (i.e., 14 
months), it is sometimes useful to investigate different phases of treatment.  Inspection of 
the growth plots indicated generally linear, but curvilinear patters were evident in many 
of the plots for a short period of time.  Most of these inflections were transient, and the 
lines would then become linear again.  For alliance researchers, an interesting question is 
whether these varying patterns are more pronounced in a particular phase of therapy?  In 
order to test this, one could construct a piecewise model.   
In order to accomplish this in the MTA data set, we essentially construct two 
separate slopes for an early phase (through Session 14) a then one for later treatment 
(Session 15 through Session 27).  The level-1 model would look like this: 
Yti=       π0i + π1i(Early Phase) + π2i(Late Phase)+ eti 
Once this is constructed, the unconditional model can assess the slope and 
volatility for each phase of treatment.  If both phases are significant, we can then identify 
how much variance is predicted by using this approach over the simple linear model.     
In order to construct the piecewise model, each observation has a coded variable 
that relates to each of the slope parameters.  Since the time variable of the linear model is 
based on the session number, the coding scheme for the separate slopes follows from that.  
However, it is difficult to describe concisely the coding scheme, because the three 
variables are coded differently depending on the particular measurement time point.  For 
this reason, we will illustrate with an example from the data set.     
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The following is a case from the MTA alliance data.  The dummy codes early and 
late signify which phase of treatment each repeated measure was collected in.  The 
variable “Session” is the parent-training session that therapeutic alliance was observed.  
Since no alliance data was collected prior to Session 2, session number was centered on 
Session 2 (i.e., becoming the session representing the intercept).  From this centered 
variable, the piecewise model is constructed by constructing two slope parameters that 
will selectively estimate a particular phase of treatment.  These slope variables are called 
early_slp and late_slp.  The variables are shown below from subject 3420:     
 
id early late Session Centered Early_slp Late_slp 
3420 1 0 2 0 0 0 
3420 1 0 5 3 3 0 
3420 1 0 11 9 9 0 
3420 1 0 12 10 10 0 
3420 0 1 14 12 12 0 
3420 0 1 16 14 12 2 
3420 0 1 17 15 12 3 
3420 0 1 23 21 12 9 
3420 0 1 24 22 12 10 
3420 0 1 25 23 12 11 
   
As this illustrates, early_slp is coded exactly the same as unconditional time 
variable for measurement points in that phase.  For subsequent measurement points, it is 
coded as the last recorded alliance point in the early phase.  Subsequent time points are 
coded similarly except they must subtract the last measurement session of the previous 
time point from their respective days from baseline.   
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APPENDIX B 
 
PATTERN MIXTURE ANALYSIS DUMMY CODING 
Hedecker & Gibbons (1997) describe several dummy coding systems that can be 
used to model missing data patterns.  Many times differences between all possible 
missing data pattern cannot be evaluated because some categories are not realized 
adequately in the sample.  In these cases, coding schemes that can both model incomplete 
vs. complete data patterns and represent a large proportion of the sample should be 
implemented.  The two coding schemes that were used for this pattern mixture analysis 
compared either complete vs. incomplete data or compared complete data vs. those that 
initially participated and then dropped out for all subsequent data collection periods.  The 
dummy coding strategies for both schemes is described below.  The incomplete coding 
scheme adds a dummy code in the model that will represent the effect having anything 
but complete data.  The monotone coding scheme adds two dummy codes (i.e., M1 and 
M2) that are entered simultaneously.  When these two are added to the level-2 model, 
each missing data pattern is compared respectively to subjects with complete data.  Both 
the “incomplete” and “monotone” coding schemes can represent large proportions of the 
overall alliance sample (100% and 75%, respectively) and address the question if 
differential missing data patterns can predict the course of alliance or treatment outcome.   
Missing Pattern D1 D2 D3 D4 D5 D6 M1 M2 Incomplete 
 
Obs./Obs./Obs. 0 0 0 0 0 0 0 0 0 
Obs./Obs./Msg. 1 0 0 0 0 0 0 1 1 
Obs./Msg./Msg. 0 1 0 0 0 0 1 0 1 
Msg./Msg./Obs. 0 0 1 0 0 0   1 
Msg./Obs./Obs. 0 0 0 1 0 0   1 
Obs./Msg./Obs. 0 0 0 0 1 0   1 
Msg./Obs./Msg. 0 0 0 0 0 1   1 
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